| Title: |
Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium. |
| Authors: |
Neslund-Dudas, Christine, Tang, Amy, Alleman, Elizabeth, Zarins, Katie R., Li, Pin, Simoff, Michael J., Lafata, Jennifer Elston, Rendle, Katharine A., Hartman, Andrea N. Burnett, Honda, Stacey A., Oshiro, Caryn, Olaiya, Oluwatosin, Greenlee, Robert T., Vachani, Anil, Ritzwoller, Debra P. |
| Source: |
JGIM: Journal of General Internal Medicine; Feb2024, Vol. 39 Issue 2, p186-194, 9p |
| Subject Terms: |
EARLY detection of cancer, CONSORTIA, LUNG cancer, RACE, UNIVARIATE analysis, MEDICAL screening |
| Abstract: |
Background: Uptake of lung cancer screening (LCS) has been slow with less than 20% of eligible people who currently or formerly smoked reported to have undergone a screening CT. Objective: To determine individual-, health system-, and neighborhood-level factors associated with LCS uptake after a provider order for screening. Design and Subjects: We conducted an observational cohort study of screening-eligible patients within the Population-based Research to Optimize the Screening Process (PROSPR)–Lung Consortium who received a radiology referral/order for a baseline low-dose screening CT (LDCT) from a healthcare provider between January 1, 2015, and June 30, 2019. Main Measures: The primary outcome is screening uptake, defined as LCS-LDCT completion within 90 days of the screening order date. Key Results: During the study period, 18,294 patients received their first order for LCS-LDCT. Orders more than doubled from the beginning to the end of the study period. Overall, 60% of patients completed screening after receiving their first LCS-LDCT order. Across health systems, uptake varied from 41 to 87%. In both univariate and multivariable analyses, older age, male sex, former smoking status, COPD, and receiving care in a centralized LCS program were positively associated with completing LCS-LDCT. Unknown insurance status, other or unknown race, and lower neighborhood socioeconomic status, as measured by the Yost Index, were negatively associated with screening uptake. Conclusions: Overall, 40% of patients referred for LCS did not complete a LDCT within 90 days, highlighting a substantial gap in the lung screening care pathway, particularly in decentralized screening programs. [ABSTRACT FROM AUTHOR] |
|
Copyright of JGIM: Journal of General Internal Medicine is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
